Addressing the underlying molecular mechanism, this study revealed that LDHB silencing combined with RT resulted in increased DNA damage accumulation in NSCLC cells compared to either treatment alone (Fig. 2H-J). Here, LDHB is linked to non-small cell lung carcinoma.